{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:50:01Z","timestamp":1792043401918,"version":"4.4.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020552","name":"Ministry of Higher Education, Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020098","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["821528"],"award-info":[{"award-number":["821528"]}],"id":[{"id":"10.13039\/100020098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004434","name":"Universit\u00e0 degli Studi di Firenze","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011045","name":"Minist\u00e8re de l'Enseignement sup\u00e9rieur, de la Recherche et de l'Innovation","doi-asserted-by":"publisher","award":["22542-2019102211127150 v2"],"award-info":[{"award-number":["22542-2019102211127150 v2"]}],"id":[{"id":"10.13039\/501100011045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011045","name":"Minist\u00e8re de l'Enseignement sup\u00e9rieur, de la Recherche et de l'Innovation","doi-asserted-by":"publisher","award":["28498-2019102211127150 v3"],"award-info":[{"award-number":["28498-2019102211127150 v3"]}],"id":[{"id":"10.13039\/501100011045","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.tox.2024.153998","type":"journal-article","created":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T15:05:47Z","timestamp":1731855947000},"page":"153998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The challenge to identify sensitive safety biomarkers of peripheral neurotoxicity in the rat: A collaborative effort across industry and academia (IMI NeuroDeRisk project)"],"prefix":"10.1016","volume":"510","author":[{"given":"Laura","family":"Micheli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Balayssac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Busserolles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristelle","family":"Dalbos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Prival","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Di Cesare Mannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Toti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Ciampi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Ghelardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Vlasakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren E.","family":"Glaab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Loryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Perrault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Slaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuno","family":"Wuersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Frieauff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelley","family":"Penraat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Brees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Dubost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diethilde","family":"Theil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2024.153998_bib1","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.tips.2024.08.001","article-title":"Neurofilament light chain as a biomarker of chemotherapy-induced peripheral neuropathy","volume":"45","author":"Andersen","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tox.2024.153998_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.critrevonc.2011.04.012","article-title":"Chemotherapy-induced peripheral neurotoxicity (CIPN): an update","volume":"82","author":"Argyriou","year":"2012","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.tox.2024.153998_bib3","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.nurt.2009.07.003","article-title":"Animal models of chemotherapy-evoked painful peripheral neuropathies","volume":"6","author":"Authier","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.tox.2024.153998_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115535","article-title":"Neurofilament light chain in plasma as a sensitive diagnostic biomarker of peripheral neurotoxicity: In Vivo mouse studies with oxaliplatin and paclitaxel - NeuroDeRisk project","volume":"167","author":"Balayssac","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tox.2024.153998_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejphar.2014.04.028","article-title":"Serotonergic modulation in neuropathy induced by oxaliplatin: Effect on the 5HT2C receptor","volume":"735","author":"Baptista-de-Souza","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tox.2024.153998_bib6","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1177\/0192623312474865","article-title":"STP Position Paper: Recommended Practices for Sampling and Processing the Nervous System (Brain, Spinal Cord, Nerve, and Eye) during Nonclinical General Toxicity Studies","volume":"41","author":"Bolon","year":"2013","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tox.2024.153998_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113154","article-title":"Methods for in vivo studies in rodents of chemotherapy induced peripheral neuropathy","volume":"325","author":"Bruna","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tox.2024.153998_bib8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s40487-021-00168-y","article-title":"Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment","volume":"9","author":"Burgess","year":"2021","journal-title":"Oncol. Ther."},{"key":"10.1016\/j.tox.2024.153998_bib9","first-page":"389","article-title":"Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration","volume":"21","author":"Cavaletti","year":"2000","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.tox.2024.153998_bib10","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.3390\/cancers15174216","article-title":"Studies to Assess the Utility of Serum Neurofilament Light Chain as a Biomarker in Chemotherapy-Induced Peripheral Neuropathy","volume":"15","author":"Cavaletti","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.tox.2024.153998_bib11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/psp4.12383","article-title":"A Network Pharmacology Approach for the Identification of Common Mechanisms of Drug-Induced Peripheral Neuropathy","volume":"8","author":"de Anda-J\u00e1uregui","year":"2019","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"10.1016\/j.tox.2024.153998_bib12","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.1933","article-title":"Assessment of Mechanical Allodynia in Rats Using the Electronic Von Frey Test","volume":"6","author":"Ferrier","year":"2016","journal-title":"BIO-Protoc."},{"key":"10.1016\/j.tox.2024.153998_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.48593","article-title":"Types and Concentrations of Blood-Based Biomarkers in Adults With Peripheral Neuropathies: A Systematic Review and Meta-analysis","volume":"5","author":"Fundaun","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.tox.2024.153998_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/brainsci8020033","article-title":"New Insights into the Role of Neuron-Specific Enolase in Neuro-Inflammation, Neurodegeneration, and Neuroprotection","volume":"8","author":"Haque","year":"2018","journal-title":"Brain Sci."},{"key":"10.1016\/j.tox.2024.153998_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12987-024-00519-7","article-title":"Analysis of the contributing role of drug transport across biological barriers in the development and treatment of chemotherapy-induced peripheral neuropathy","volume":"21","author":"Hu","year":"2024","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.tox.2024.153998_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.154395","article-title":"Neurofilament proteins as a potential biomarker in chemotherapy-induced polyneuropathy","volume":"7","author":"Huehnchen","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.tox.2024.153998_bib17","unstructured":"Jain, K.K., 2012. Drug-induced neurological disorders, 3rd rev. and expanded ed. ed. Hogrefe Pub., Cambridge, MA."},{"key":"10.1016\/j.tox.2024.153998_bib18","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.annonc.2020.07.003","article-title":"Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO\u2013EONS\u2013EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up","volume":"31","author":"Jordan","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.tox.2024.153998_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.131","article-title":"Incorporation of concentration data below the limit of quantification in population pharmacokinetic analyses","volume":"3","author":"Keizer","year":"2015","journal-title":"Pharmacol. Res Perspec"},{"key":"10.1016\/j.tox.2024.153998_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00086","article-title":"Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review","volume":"8","author":"Kerckhove","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tox.2024.153998_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.tox.2024.153998_bib22","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1476-5381.1988.tb10310.x","article-title":"\u03ba-Opioid agonists produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat","volume":"93","author":"Leighton","year":"1988","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tox.2024.153998_bib23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pain.2006.09.016","article-title":"Behavioral and pharmacological description of oxaliplatin-induced painful neuropathy in rat","volume":"128","author":"Ling","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.tox.2024.153998_bib24","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1177\/0192623312438738","article-title":"International Harmonization of Toxicologic Pathology Nomenclature: An Overview and Review of Basic Principles","volume":"40","author":"Mann","year":"2012","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tox.2024.153998_bib25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.expneurol.2018.06.005","article-title":"Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy","volume":"307","author":"Meregalli","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tox.2024.153998_bib26","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1007\/s00204-020-02755-w","article-title":"Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity","volume":"94","author":"Meregalli","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2024.153998_bib27","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s13046-021-02127-x","article-title":"VEGF-A\/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody","volume":"40","author":"Micheli","year":"2021","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.tox.2024.153998_bib28","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.36695","article-title":"Hemoglobin, Body Mass Index, and Age as Risk Factors for Paclitaxel- and Oxaliplatin-Induced Peripheral Neuropathy","volume":"4","author":"Mizrahi","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.tox.2024.153998_bib29","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1097\/j.pain.0000000000002840","article-title":"Neurofilament light chain as a biomarker of axonal damage in sensory neurons and paclitaxel-induced peripheral neuropathy in patients with ovarian cancer","volume":"164","author":"Mortensen","year":"2023","journal-title":"Pain"},{"key":"10.1016\/j.tox.2024.153998_bib30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12862-020-01684-7","article-title":"Molecular evolutionary and structural analysis of human UCHL1 gene demonstrates the relevant role of intragenic epistasis in Parkinson\u2019s disease and other neurological disorders","volume":"20","author":"Nawaz","year":"2020","journal-title":"BMC Evol. Biol."},{"key":"10.1016\/j.tox.2024.153998_bib31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/mus.21323","article-title":"Glial fibrillary acidic protein as a marker of axonal damage in chronic neuropathies: Marker of Axonal Damage","volume":"40","author":"Notturno","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.tox.2024.153998_bib32","doi-asserted-by":"crossref","unstructured":"Pardridge, W.M., 2012. Drug Transport across the Blood\u2013Brain Barrier.","DOI":"10.1038\/jcbfm.2012.126"},{"issue":"2","key":"10.1016\/j.tox.2024.153998_bib33","first-page":"S13","article-title":"Overview and critical revision of clinical assessment tools in chemotherapy-induced peripheral neurotoxicity","volume":"24","author":"Park","year":"2019","journal-title":"J. Peripher Nerv. Syst."},{"key":"10.1016\/j.tox.2024.153998_bib34","series-title":"in: International Review of Neurobiology","first-page":"81","article-title":"Chapter 5 Methods and Protocols in Peripheral Nerve Regeneration Experimental Research","author":"Raimondo","year":"2009"},{"key":"10.1016\/j.tox.2024.153998_bib35","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/0192623318761348","article-title":"Use of Severity Grades to Characterize Histopathologic Changes","volume":"46","author":"Schafer","year":"2018","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tox.2024.153998_bib36","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1054\/bjoc.1999.1026","article-title":"Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs","volume":"82","author":"Screnci","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tox.2024.153998_bib37","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3390\/ijms19040998","article-title":"The Neurotoxic Role of Extracellular Tau Protein","volume":"19","author":"Sebasti\u00e1n-Serrano","year":"2018","journal-title":"IJMS"},{"key":"10.1016\/j.tox.2024.153998_bib38","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.3390\/jcm9082400","article-title":"Long-Term Prevalence of Sensory Chemotherapy-Induced Peripheral Neuropathy for 5 Years after Adjuvant FOLFOX Chemotherapy to Treat Colorectal Cancer: A Multicenter Cross-Sectional Study","volume":"9","author":"Selvy","year":"2020","journal-title":"JCM"},{"key":"10.1016\/j.tox.2024.153998_bib39","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis","volume":"155","author":"Seretny","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.tox.2024.153998_bib40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/01926233231180179","article-title":"Neurofilament Light Chain: A Translational Safety Biomarker for Drug-Induced Peripheral Neurotoxicity","volume":"51","author":"Theil","year":"2023","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tox.2024.153998_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16369","article-title":"Plasma neurofilament light chain levels in chemotherapy-induced peripheral neurotoxicity according to type of anticancer drug","volume":"31","author":"Velasco","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.tox.2024.153998_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1285359","article-title":"Performance of biomarkers NF-L, NSE, Tau and GFAP in blood and cerebrospinal fluid in rat for the detection of nervous system injury","volume":"17","author":"Vlasakova","year":"2024","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.tox.2024.153998_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fpain.2021.683168","article-title":"Impact of Dose, Sex, and Strain on Oxaliplatin-Induced Peripheral Neuropathy in Mice","volume":"2","author":"Warncke","year":"2021","journal-title":"Front. Pain. Res."},{"key":"10.1016\/j.tox.2024.153998_bib44","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/1091581810391818","article-title":"Differences in Rat Models Used in Routine Toxicity Studies","volume":"30","author":"Weber","year":"2011","journal-title":"Int J. Toxicol."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X24002798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X24002798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T22:13:39Z","timestamp":1733696019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X24002798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":44,"alternative-id":["S0300483X24002798"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2024.153998","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The challenge to identify sensitive safety biomarkers of peripheral neurotoxicity in the rat: A collaborative effort across industry and academia (IMI NeuroDeRisk project)","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2024.153998","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"153998"}}